Probi AB (Sweden) Analysis

PROB Stock  SEK 350.00  1.00  0.28%   
Probi AB is overvalued with Real Value of 294.84 and Hype Value of 351.0. The main objective of Probi AB stock analysis is to determine its intrinsic value, which is an estimate of what Probi AB is worth, separate from its market price. There are two main types of Probi AB's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Probi AB's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Probi AB's stock to identify patterns and trends that may indicate its future price movements.
The Probi AB stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Probi AB is usually not traded on NationalDay, International Workers ' Day, St . John 's Day, All Saints ' Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day, Epiphany, Good Friday, Easter Sunday, Easter Monday. Probi Stock trading window is adjusted to Europe/Stockholm timezone.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Probi AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Probi Stock Analysis Notes

About 69.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.61. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Probi AB recorded earning per share (EPS) of 6.26. The entity last dividend was issued on the 6th of May 2022. The firm had 230:217 split on the 5th of October 2016. Probi AB , a bioengineering company, researches, develops, manufactures, markets, and sells probiotics for food, health, and pharmaceutical companies. The company was founded in 1991 and is headquartered in Lund, Sweden. Probi AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 164 people. To find out more about Probi AB contact the company at 46 4 62 86 89 20 or learn more at https://www.probi.com.

Probi AB Investment Alerts

Probi AB is way too risky over 90 days horizon
Probi AB appears to be risky and price may revert if volatility continues
About 69.0% of the company outstanding shares are owned by corporate insiders

Probi Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.08 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Probi AB's market, we take the total number of its shares issued and multiply it by Probi AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Probi Profitablity

Probi AB's profitability indicators refer to fundamental financial ratios that showcase Probi AB's ability to generate income relative to its revenue or operating costs. If, let's say, Probi AB is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Probi AB's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Probi AB's profitability requires more research than a typical breakdown of Probi AB's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.08 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.08.

Technical Drivers

As of the 22nd of November, Probi AB holds the Semi Deviation of 2.62, coefficient of variation of 1029.11, and Risk Adjusted Performance of 0.0828. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Probi AB, as well as the relationship between them.

Probi AB Price Movement Analysis

Execute Study
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Probi AB middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Probi AB. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Probi AB Outstanding Bonds

Probi AB issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Probi AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Probi bonds can be classified according to their maturity, which is the date when Probi AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Probi AB Predictive Daily Indicators

Probi AB intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Probi AB stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Probi AB Forecast Models

Probi AB's time-series forecasting models are one of many Probi AB's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Probi AB's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Probi Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Probi AB prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Probi shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Probi AB. By using and applying Probi Stock analysis, traders can create a robust methodology for identifying Probi entry and exit points for their positions.
Probi AB , a bioengineering company, researches, develops, manufactures, markets, and sells probiotics for food, health, and pharmaceutical companies. The company was founded in 1991 and is headquartered in Lund, Sweden. Probi AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 164 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Probi AB to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Price Ceiling Movement Now

   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
All  Next Launch Module

Additional Tools for Probi Stock Analysis

When running Probi AB's price analysis, check to measure Probi AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Probi AB is operating at the current time. Most of Probi AB's value examination focuses on studying past and present price action to predict the probability of Probi AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Probi AB's price. Additionally, you may evaluate how the addition of Probi AB to your portfolios can decrease your overall portfolio volatility.